Erysipelotrichales

   RANK: Order

TAXONOMY: cellular organisms -> Bacteria -> Terrabacteria group -> Firmicutes -> Erysipelotrichia -> Erysipelotrichales

OVERVIEW:

Inflammatory bowel diseases (IBDs), including Crohn's disease (CD), are genetically linked to host pathways that implicate an underlying role for aberrant immune responses to intestinal microbiota. However, patterns of gut microbiome dysbiosis in IBD patients are inconsistent among published studies. Using samples from multiple gastrointestinal locations collected prior to treatment in new-onset cases, we studied the microbiome in the largest pediatric CD cohort to date. An axis defined by an increased abundance in bacteria which include Enterobacteriaceae, Pasteurellacaea, Veillonellaceae, and Fusobacteriaceae, and decreased abundance in Erysipelotrichales, Bacteroidales, and Clostridiales, correlates strongly with disease status. [PMID: 24629344]



Microbial Abundance Data: Erysipelotrichales
(Percent of total population with standard deviation [PMID: 22698087])
Group 1
Group 2
Group 3
Group 4
Group 1 Avg
Buccal
Mucosa
Keratinized
Gingiva
Hard
Palate
Group 2 Avg
Throat
Throat
Tonsils
Saliva
Group 3 Avg
Supragingival
Plaque
Subgingival
Plaque
Stool
0.046 %
(0.104)
0.015 %
(0.037)
0.002 %
(0.006)
0.121 %
(0.268)
0.138 %
(0.263)
0.161 %
(0.345)
0.147 %
(0.284)
0.134 %
(0.198)
0.112 %
(0.224)
0.011 %
(0.041)
0.004 %
(0.011)
0.019 %
(0.072)
0.308 %
(0.546)
TAGS
Keystone Core species Type species Pathogen Dysbiosis associated Flora/ commensal Gut associated Probiotic
Leanness Obesity Skin microbiome Fecal distribution Oral microbiome Vaginal microbiome Butyrate producer Catalase producer
Histamine producer Food fermenter Amylolytic Propionate producer Nitrifying
DESCENDANTS
INTERACTIONS
KEGG PATHWAYS

CLUSTERS WITH
METABOLOMICS       
NUTRIENTS/ SUBSTRATES
  • Polyphenol

  • ENDPRODUCTS

    INHIBITED BY
  • Walnuts [parent]

  • ENHANCED BY
  • High sugar diet [parent]
  • Partial Sleep Deprivation
  • High fat diet [parent]

  • BIOTRANSFORMS

    BIOTRANFORM
    ANTIBIOTIC RESISTANCE   
    BIOFILM FORMERS   
    COGEM PATHOGENICITY   

    OPUS 23™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015-2023. ALL RIGHTS RESERVED.     |